Information Provided By:
Fly News Breaks for January 31, 2019
ANTM
Jan 31, 2019 | 08:34 EDT
SunTrust analyst David MacDonald raised his price target on Anthem to $340 after its Q4 earnings beat, saying the results were driven by "attractive core trends, stable Medicare cover ratio, ongoing efficiency initiatives and solid cash flows". The analyst also cites the company's strong 2019 guidance and acceleration of IngenioRx launch, but sees risk-reward as balanced given the competitive nature of the company commercial market.
News For ANTM From the Last 2 Days
There are no results for your query ANTM